An additional report suggested that pharmacological systemic P53 activation can even ameliorate chemically induced diabetes [40], while ablation of one key inhibitor of P53 (MDM2) resulted in reduced insulin secretion without any effect on beta cell mass [68]. This evidence concerns the gene MDM2 and diabetes mellitus.